MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Genetic variants detection and prevalence in Hawaii’s diverse PD population

    M. Faouzi, K. Thai, R. Shuman, E. Krening, A. Yake, F. Gao, M. Bruno (Hawaii, USA)

    Objective: To overcome access barriers to genetic testing and address the paucity of knowledge regarding genetic causes of PD among Hawaii’s racial and ethnic groups.…
  • 2025 International Congress

    Unveiling Parkinson’s Disease Variants in the Chinese Population: The CPD10KGP Study

    Y. Zhao, Z. Liu, H. Pan, J. Guo, B. Tang (Changsha, China)

    Objective: In response to these limitations, we are proposing the China Parkinson’s Disease 10,000 Genomes Project (CPD10KGP), which aims to delineate the genetic architecture of…
  • 2025 International Congress

    The role of imaging in deep brain stimulation programming: a preliminary comparative study of image-guided vs. neuroimaging-guided automated approaches in Parkinson’s disease

    J. Bejarano Hernandez, A. Sánchez Gómez, A. Martinez Reyes, F. Valldeoriola Serra (Barcelona, Spain)

    Objective: To evaluate the imaging correlation between image-guided and neuroimaging-guided automated of bilateral STN stimulation in patients with PD. Background: Subthalamic deep brain stimulation (STN-DBS)…
  • 2025 International Congress

    Levodopa and DBS Produce Discordant Effects on Parkinsonian Features

    T. Lee, D. Ramesh, J. Perlmutter, J. Younce (Chapel Hill, USA)

    Objective: To compare the effect of levodopa vs deep brain stimulation on specific motor features of advanced Parkinson disease. Background: Levodopa (LD) is the gold…
  • 2025 International Congress

    Value of local field potential-based deep brain stimulation programming in Parkinson’s disease

    C. Gonzalez-Robles, J. Candelario-Mckeown, C. Duraffourd, M. Krueger, M. Mancuso, L. Mooney, H. Akram, J. Hyam, T. Foltynie, S. Xu, L. Zrinzo, P. Limousin (London, United Kingdom)

    Objective: To report preliminary data on the utility of local field potential(LFP)-based programming in bilateral subthalamic nucleus(STN) deep brain stimulation(DBS) for Parkinson’s disease(PD). Background: Current…
  • 2025 International Congress

    The Impact of Bilateral GPi Deep Brain Stimulation on Non-Motor Symptoms in Parkinson’s Disease

    J. Lee, S. Jo, M. Choi, SJ. Chung (Goyang-si, Republic of Korea)

    Objective: This study aimed to evaluate how bilateral Globus Pallidus internus (GPi) Deep Brain Stimulation (DBS) affects non-motor symptoms in individuals diagnosed with Parkinson’s disease…
  • 2025 International Congress

    Impact of IPX203 (ER CD-LD) on nighttime sleep in patients with Parkinson’s disease experiencing motor fluctuations: A post hoc analysis of the RISE-PD trial

    R. Hauser, A. Espay, O. Vaou, J. Aldred, S. Allard, G. Banisadr, S. Fisher (Tampa, USA)

    Objective: To explore the effects of IPX203 on nighttime sleep and motor states in patients with Parkinson’s disease (PD) experiencing motor fluctuations. Background: Sleep disturbances…
  • 2025 International Congress

    Risk Factors and Outcome of Dopamine Dysregulation Syndrome in a large Chinese Parkinson’s Disease Cohort

    Y. Xiao, S. Kang, R. Ou, W. Song, H. Shang (Chengdu, China)

    Objective: We conducted a large-sample study to investigate the clinical characteristics and related risk factors of DDS in China. In addition, we further followed up…
  • 2025 International Congress

    The role of serotonergic mechanisms in the formation of levodopa-induced drug-induced dyskinesias in Parkinson’s disease

    D. Pulatova, F. Saidvaliev (Tashkent, Uzbekistan)

    Objective: To study the quantitative content of serotonin and dopamine in the blood plasma of patients with Parkinson's disease and to conduct a clinical and…
  • 2025 International Congress

    Alterations in gut microbiota composition in VPS35 associated PARK17 mouse model

    TH. Yeh, SP. Tsao, HY. Huang, CC. Chiu (Taipei, Taiwan)

    Objective: This study explores whether host genetics such as specific VPS35 genetic variations linked to PD can shape the gut microbiome. Background: Heterozygous (D620N) mutation…
  • « Previous Page
  • 1
  • …
  • 65
  • 66
  • 67
  • 68
  • 69
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley